Navidea Biopharmaceuticals, Inc.

NAVB · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$1,996$4,231$2,670$1,047
Short-Term Investments$0$0$0$0
Receivables$1$93$2,987$901
Inventory$427$151$170-$901
Other Curr. Assets$780$908$701$1,869
Total Curr. Assets$3,204$5,383$6,528$2,916
Property Plant & Equip (Net)$156$249$382$312
Goodwill$0$0$0$0
Intangibles$1,000$786$620$385
Long-Term Investments$0$0$15,275$0
Tax Assets$0$0-$15,275$0
Other NC Assets$12$227$227$538
Total NC Assets$1,168$1,262$1,230$1,235
Other Assets$0$0$0$0
Total Assets$4,372$6,645$7,758$4,151
Liabilities
Payables$2,123$1,421$1,162$1,112
Short-Term Debt$563$729$1,040$807
Tax Payable$0$0$0$0
Deferred Revenue$800$41$0$700
Other Curr. Liab.$6,457$3,109$2,513$1,200
Total Curr. Liab.$9,942$5,300$4,715$3,820
LT Debt$1,873$20$296$512
Deferred Rev, NC$700$700$700$700
Deferred Tax Liab, NC$0-$20$0-$512
Other NC Liab.$0$0$0$0
Total NC Liab.$2,573$720$996$1,212
Other Liabilities$0$0$0$0
Cap. Leases$20$296$591$763
Total Liabilities$12,515$6,020$5,711$5,032
Equity
Pref Stock$0$0$0$0
Common Stock$224$221$218$210
Retained Earnings-$388,003-$370,788-$359,057-$347,671
AOCI$0$0$0$1
Other Equity$379,343$370,460$360,154$345,849
Total Equity-$8,436-$107$1,316-$1,612
Supplemental Information
Minority Interest$293$731$731$731
Total Liab. & Tot. Equity$4,372$6,645$7,758$4,151
Net Debt$440-$3,481-$1,334$272